707 related articles for article (PubMed ID: 11735093)
1. Beneficial effects of metformin in normoglycemic morbidly obese adolescents.
Kay JP; Alemzadeh R; Langley G; D'Angelo L; Smith P; Holshouser S
Metabolism; 2001 Dec; 50(12):1457-61. PubMed ID: 11735093
[TBL] [Abstract][Full Text] [Related]
2. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A
Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
[TBL] [Abstract][Full Text] [Related]
3. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30.
Glueck CJ; Fontaine RN; Wang P; Subbiah MT; Weber K; Illig E; Streicher P; Sieve-Smith L; Tracy TM; Lang JE; McCullough P
Metabolism; 2001 Jul; 50(7):856-61. PubMed ID: 11436194
[TBL] [Abstract][Full Text] [Related]
4. The effects of metformin and diet on plasma testosterone and leptin levels in obese men.
Ozata M; Oktenli C; Bingol N; Ozdemir IC
Obes Res; 2001 Nov; 9(11):662-7. PubMed ID: 11707532
[TBL] [Abstract][Full Text] [Related]
5. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin.
Chazova I; Almazov VA; Shlyakhto E
Diabetes Obes Metab; 2006 Jul; 8(4):456-65. PubMed ID: 16776753
[TBL] [Abstract][Full Text] [Related]
6. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?
Onalan G; Goktolga U; Ceyhan T; Bagis T; Onalan R; Pabuçcu R
Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):204-11. PubMed ID: 16316811
[TBL] [Abstract][Full Text] [Related]
8. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.
Nolan JJ; Ludvik B; Beerdsen P; Joyce M; Olefsky J
N Engl J Med; 1994 Nov; 331(18):1188-93. PubMed ID: 7935656
[TBL] [Abstract][Full Text] [Related]
9. Short-term metabolic and cardiovascular effects of metformin in markedly obese adolescents with normal glucose tolerance.
Burgert TS; Duran EJ; Goldberg-Gell R; Dziura J; Yeckel CW; Katz S; Tamborlane WV; Caprio S
Pediatr Diabetes; 2008 Dec; 9(6):567-76. PubMed ID: 18761646
[TBL] [Abstract][Full Text] [Related]
10. Short-term effects of metformin in type 2 diabetes.
Eriksson A; Attvall S; Bonnier M; Eriksson JW; Rosander B; Karlsson FA
Diabetes Obes Metab; 2007 Jul; 9(4):483-9. PubMed ID: 17587390
[TBL] [Abstract][Full Text] [Related]
11. Use of quality control indices in moderately hypocaloric Mediterranean diet for treatment of obesity.
De Lorenzo A; Petroni ML; De Luca PP; Andreoli A; Morini P; Iacopino L; Innocente I; Perriello G
Diabetes Nutr Metab; 2001 Aug; 14(4):181-8. PubMed ID: 11716286
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effect of diazoxide in obese hyperinsulinemic adults.
Alemzadeh R; Langley G; Upchurch L; Smith P; Slonim AE
J Clin Endocrinol Metab; 1998 Jun; 83(6):1911-5. PubMed ID: 9626118
[TBL] [Abstract][Full Text] [Related]
13. Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio.
Mulligan K; Yang Y; Wininger DA; Koletar SL; Parker RA; Alston-Smith BL; Schouten JT; Fielding RA; Basar MT; Grinspoon S
AIDS; 2007 Jan; 21(1):47-57. PubMed ID: 17148967
[TBL] [Abstract][Full Text] [Related]
14. Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial.
Fontbonne A; Diouf I; Baccara-Dinet M; Eschwege E; Charles MA
Diabetes Metab; 2009 Nov; 35(5):385-91. PubMed ID: 19665415
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of leptin and its potential humoral regulators in long-term low-calorie diet therapy for obese humans.
Miyawaki T; Masuzaki H; Ogawa Y; Hosoda K; Nishimura H; Azuma N; Sugawara A; Masuda I; Murata M; Matsuo T; Hayashi T; Inoue G; Yoshimasa Y; Nakao K
Eur J Clin Nutr; 2002 Jul; 56(7):593-600. PubMed ID: 12080397
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effect of low carbohydrate in low calorie diets on visceral fat reduction in type 2 diabetic patients with obesity.
Miyashita Y; Koide N; Ohtsuka M; Ozaki H; Itoh Y; Oyama T; Uetake T; Ariga K; Shirai K
Diabetes Res Clin Pract; 2004 Sep; 65(3):235-41. PubMed ID: 15331203
[TBL] [Abstract][Full Text] [Related]
17. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
Sharma PK; Bhansali A; Sialy R; Malhotra S; Pandhi P
Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
[TBL] [Abstract][Full Text] [Related]
18. Double blind clinical trial of mazindol on weight loss blood glucose, plasma insulin and serum lipids in overweight diabetic patients.
Slama G; Selmi A; Hautecouverture M; Tchobroutsky G
Diabete Metab; 1978 Sep; 4(3):193-9. PubMed ID: 361463
[TBL] [Abstract][Full Text] [Related]
19. Metformin in the treatment of obesity in subjects with normal glucose tolerance.
Tankova T; Dakovska L; Kirilov G; Koev D
Rom J Intern Med; 2003; 41(3):269-75. PubMed ID: 15526510
[TBL] [Abstract][Full Text] [Related]
20. Effects of a combination of rhGH and metformin on adiponectin levels in patients with metabolic syndrome.
Herrmann BL; Saller B; Stratmann M; Berg C; Mann K; Janssen OE
Horm Metab Res; 2005 Jan; 37(1):49-52. PubMed ID: 15702440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]